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Abstract
Apoptotic cells are commonly observed in a broad range of tissues during
mammalian embryonic and fetal development. Specific requirements and
functions of programmed cell death were inferred from early observations.
These inferences did not hold up to functional proof for a requirement of
apoptosis for normal tissue development in all cases. In this review, we
summarize how the appraisal of the importance of developmental apoptosis
has changed over the years, in particular with detailed functional
assessment, such as by using gene-targeted mice lacking essential
initiators or mediators of apoptosis. In recent years, the essentials of
developmental apoptosis have emerged. We hypothesize that apoptosis is
predominantly required to balance cell proliferation. The two
interdependent processes—cell proliferation and apoptosis—together more
powerfully regulate tissue growth than does each process alone. We
proposed that this ensures that tissues and cell populations attain the
appropriate size that allows fusion in the body midline and retain the size of
cavities once formed. In addition, a limited number of tissues, albeit not all
previously proposed, rely on apoptosis for remodeling, chiefly aortic arch
remodeling, elimination of supernumerary neurons, removal of vaginal
septa, and removal of interdigital webs in the formation of hands and feet.
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Introduction
The observation that cells can undergo cell death during devel-
opment was first made in the 1920s (reviewed in 1). The 
morphology of these dying cells was found to be distinctly dif-
ferent than that observed in necrotic cells (for example, cells 
subjected to injury). Isolated cells or at most small clusters 
of cells undergo cell death during normal development. Cells 
undergoing cell death during embryonic development shrink 
rather than rupture as seen in necrosis (Figure 1); cell nuclei 
condense in what is termed pyknosis (from the Greek pykno, 
meaning thick, compact, or dense) and ultimately fragment. The 
components of such dying cells are packaged into cytoplasmic 
membrane–enclosed vesicles awaiting phagocytosis by other 
cells. In contrast, during necrosis, which can occur during injury 
and inflammation, larger areas of tissue are usually affected, 
cells swell, the plasma membrane and nuclear envelope rupture, 
and cell contents spill out.
The predictable time course and location of the dying cells dur-
ing development suggested that it was a regulated process and 
the term programmed cell death was used to indicate this con-
cept. Based on the time course and location, the essential roles 
of programmed cell death during development—including 
requirement for tissue invagination and closure, union of body 
halves, lumen formation, bifurcation, regression of rudimen-
tary organs, and cell differentiation—were inferred1. Later, 
the electron microscopic characteristics of the dying cells 
were described and the term apoptosis (from the Greek apo + 
ptosis, meaning from + falling) was coined (reviewed in 2). The 
cell membrane–bound fragments of apoptotic cells were termed 
apoptotic bodies. Apoptosis is thought to drive morphogenesis 
by regulating cell number, tissue sculpturing, and deleting 
structures, including the conversion of solid structures into 
tubes and vesicles3.
Regulation of apoptosis
In the following decades, a large number of researchers worked 
to decipher the molecular mechanisms that initiate and execute 
apoptosis during development; they also determined the role 
of apoptosis in disease conditions (reviewed in 4,5). Two dis-
tinct but ultimately converging pathways initiate apoptosis6: 
the mitochondrial, intrinsic, or B-cell lymphoma 2 (BCL-2)–
regulated pathway and the extrinsic or death receptor pathway 
(Figure 2).
The mitochondrial pathway is initiated during development 
by limiting levels of growth factors, metabolic stress, lack of 
neurotrophic support, lack of blood flow, or loss of substrate 
adhesion (anoikis, from the Greek an + oikos, meaning without 
+ home) and in disease or experimental settings by DNA dam-
age and diverse cytotoxic agents. The response to these stimuli 
is regulated by BCL-2 protein family members4. In response to 
death-inducing stimuli, pro-apoptotic members of the fam-
ily (BIM, PUMA, BID, BMF, NOXA, BIK, BAD, and HRK; 
Figure 1. The morphological distinction of apoptosis and necrosis. Schematic drawing and major characteristics. EM, electron 
microscopy.
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collectively termed BH3 [BCL-2 homology domain 3]-only 
proteins) inhibit the anti-apoptotic BCL-2 family members 
(BCL-2, MCL-1, BCL-XL, BCL-W, and A1/BFL-1), which 
under steady-state conditions keep the pro-apoptotic effectors, 
the multi-BH domain proteins BAX and BAK, in an inactive 
state. In addition, some BH3-only proteins (for example, BIM and 
PUMA) have been reported to activate BAX and BAK directly4,5. 
Once activated, BAX and BAK form pores within the mito-
chondrial outer membrane, which leads to mitochondrial outer 
membrane permeabilization (MOMP) and release of cytochrome 
C and other apoptogenic factors from the mitochondria into 
the cytoplasm (Figure 2).
Cytochrome C associates with APAF-1 and caspase-9 to form 
the apoptosome and this stimulates caspase-9 activation, which 
in turn cleaves and thereby activates effector caspase-3, -6, 
and -7. These effector caspases cleave hundreds of proteins 
and in certain cases proteolytically activate or inhibit other 
enzymes. This includes the activation of endonucleases that 
drive DNA fragmentation and the inhibition of flippases, which 
causes exposure of “eat me signals” on the plasma membrane. 
These processes lead to chromatin condensation and packag-
ing of the cell content into apoptotic bodies and removal by 
phagocytosis.
In the death receptor pathway, apoptosis is initiated by the bind-
ing of certain members of the tumor necrosis factor (TNF) fam-
ily to their cognate receptors that belong to the TNF receptor 
(TNFR) family (in particular, binding of FAS ligand [FASL] 
to its receptor FAS). This can set in train two different series 
of events: if available, pro-caspase-8, which directly activates 
effector caspase-3, -6 and -7, is activated. The pro-apoptotic 
BH3-only protein BID, after proteolytic conversion to tBID, 
can also activate the BAX/BAK-dependent mitochondrial 
apoptotic pathway to thereby amplify the apoptotic cascade 
(Figure 2). If caspase-8 is absent or inhibited (for example, by 
viral inhibitors of this protease, such as vFLIP), another form of 
regulated cell death, termed necroptosis7, can be initiated via 
receptor-interacting serine/threonine-protein kinase 1 (RIPK1), 
RIPK3, and mixed lineage kinase domain-like pseudokinase 
(MLKL) (Figure 2). These alternative fates after the activa-
tion of FAS or certain other surface receptors (for example, 
Figure 2. Simplified schematic drawing of the mitochondrial and death receptor apoptotic pathways. MOMP, mitochondrial outer 
membrane permeabilization.
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TNFR1) result in either apoptotic or necroptotic cell death with 
discernible histological morphologies (Figure 1). The form of 
cell death reported to occur during embryonic development 
resembles apoptotic cell death. Based on histological studies, 
necroptotic cell death, if it occurred during development, would 
not be common.
In the following section, we summarize originally proposed 
roles of apoptotic cell death during development and more 
recent detailed functional studies that have identified the much 
more restricted gambit of processes that critically depend on 
developmental apoptosis. In the conclusion, we propose why 
developmental apoptosis occurs in many tissues, seemingly 
without being essential.
Apoptosis during embryonic development
Histological analyses of developing embryos discovered that 
pyknotic (dying/dead) cells were present in certain locations 
at given stages of development. Diverse animal models, from 
Caenorhabditis elegans to Mus musculus, were used. In C. ele-
gans, specific individual cells destined to undergo cell death 
were identified3,8–10. In contrast, clusters of cells undergoing cell 
death in mouse embryos were noted at specific stages in specific 
regions, but death did not appear to be pre-programmed to tar-
get specific individual cells (Table 1). In mice, pyknotic cells 
were detected in a range of tissues, and it was inferred that 
their death was required for a range of developmental proc-
esses, including cavitation, vesicle and tube formation (lens, 
neural tube, and intestine), fusion of epithelial sheets (neural 
tube formation, midline body wall, and palate), removal of ves-
tigial tissue (pro-nephros, parts of meso- and meta-nephros, 
notochord, and Müllerian duct in males and Wolffian duct in 
females), and tissue cellular homeostasis (summarized in 1).
Subsequent reports proposed that apoptotic cell death was 
essential for normal development in regions where pyknotic 
cells were observed (Table 1), including for the elimination 
of redundant cells from the inner cell mass of the embryonic 
day 3 (E3.5) blastocyst11, and during the development of the 
epiblasts at E6 to E712, neural crest cells13, lens vesicle14, and the 
pro-amniotic cavity15, for digit separation by removing interdig-
ital tissue at E13.516, shaping the limbs17, neural tube closure18, 
Table 1. Examples of developmental processes proposed to rely on programmed cell death.
Year Proposed roles of apoptosis in development Reference
1951 Table of incidences of programmed cell death during development 
Including
 vesicle formation (optic vesicle, lens) 
tube formation by invagination and detachment from epithelial 
sheets (neural tube, intestine) 
lumen formation (salivary gland, duodenum, colon, vagina) 
fusion of epithelial sheets (midline body wall, palate) 
removal of vestigial tissue (pro-nephros, parts of meso and meta-
nephros, notochord, and Müllerian duct in males Wolffian duct in 
females)
Glücksmann1
1972 Morphological characteristics of developmentally programmed cell death Kerr et al.2
1980 Shaping of the epiblast Poelmann12
1989 Elimination of redundant cells from the inner cell mass of the blastocyst Pierce et al.11
1992 Kidney development Koseki et al.19
1993 Kidney developing Coles et al.20
1993 Elimination of neural crest from odd-numbered rhombomeres Graham et al.13
1994 Lens vesicle development Morgenbesser et al.14
1995 Lens vesicle development Pan and Griep21
1995 Pro-amniotic cavity formation Coucouvanis and 
Martin15
1996 Digit separation by removing interdigital tissue Jacobsen et al.16
1997 Inner ear morphogenesis Fekete et al.22
1997 Shaping the limbs Macias et al.17
1997 Chondrocytes undergo hypertrophy and apoptosis during enchondral 
bone development
Amling et al.23
1997 Neural tube closure Weil et al.18
2000 Palatal shelf fusion Martínez-Alvarez et al.24
2015 Epithelial folding Monier et al.25
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and elimination of supernumerary neurons during early postnatal 
development of the brain26.
Evidence that the mitochondrial apoptotic pathway is 
essential for mammalian development
Mice lacking individual apoptotic regulators provided evi-
dence for the requirements for specific regulators and suggested 
that developmental apoptosis was essential for mammalian 
development (Table 2).
Indeed, from the original large number of developmental proc-
esses proposed to require apoptosis to proceed normally 
(Table 1), knockout mouse studies in recent years have sin-
gled out those developmental processes that do and those 
that do not require apoptosis (Table 2). In particular, it has 
become clear that reducing apoptosis typically causes webbed 
digits, vaginal septa, and often lymphadenopathy; it com-
monly causes exencephaly and cleft face or palate and occasion-
ally omphalocele. Therefore, it can be said that the removal of 
the interdigital webbing, vaginal septa, blood cell homeostasis, 
neural tube, palate, and body wall closure depends critically on 
developmental apoptosis. However, whether development lead-
ing up to these events or the processes themselves require 
apoptosis was not discriminated by these studies. Indeed, the 
sequence of events can be complex. For example, develop-
ing neurons can undergo apoptosis before or after target 
innervation27,28. However, it appears that the lack or restriction 
of neurotrophic support may be the cause of neuronal apoptosis 
on both occasions28,29.
Technical difficulties in enumerating apoptotic cells 
during development
As a corollary of identifying developmental processes that 
require apoptosis, those processes that occur normally without 
apoptosis might also have been defined. However, to make such 
a claim with certainty, the possibility of residual apoptosis 
occurring would have to be excluded. The difficulties in assess-
ing absolute numbers of apoptotic cells during development 
can be illustrated by using the example of embryos lacking the 
tumor suppressor p53, which in response to a number of stress 
stimuli can induce either cell cycle arrest or apoptosis30,31. Male 
mice lacking a functional Trp53 gene are born in the expected 
numbers, but female Trp53–/– mice are under-represented 
because of a partially penetrant failure of neural tube closure32,33. 
Originally, electron microscopy32 and terminal deoxynucleotidyl 
transferase dUTP nick end labeling of DNA fragments (TUNEL) 
(a technique used to identify cells undergoing apoptosis) on 
sections33 were employed to determine whether loss of p53 
affected developmental apoptosis, but neither method detected 
a difference between wild-type and Trp53–/– mouse embryos. It 
was hypothesized that the methods employed may not have been 
sensitive enough to detect differences33. More recently, devel-
opmental apoptosis in Trp53–/– embryos was assessed by 
TUNEL flow cytometry on single cell suspensions and this 
method was sufficiently sensitive to detect a difference between 
Trp53–/– and wild-type embryos34. Flow cytometry proved to 
be a sensitive and precise method that also easily detected 
differences between wild-type and Bax–/–;Bak–/– double 
knockout (DKO) embryos (total absence of apoptosis)35 or 
Mcl1+/–;Bclx+/– double heterozygous mice (abnormally 
increased apoptosis)36. However, the low percentage of apop-
totic cells in developing wild-type embryos (only about 
1.5%34–36) does not provide a large dynamic range for detect-
ing a gradual reduction in apoptosis. Indeed, although the 
more severe developmental abnormalities in mice with 
combined loss of pro-apoptotic BAX, BAK, and BOK com-
pared with loss of only BAX and BAK suggested that the 
Bax–/–;Bak–/–;Bok–/– triple knockout mice (TKO) should have a 
greater reduction in developmental apoptosis than Bax–/–;Bak–/– 
DKO mice, flow cytometric analysis was unable to detect 
significant differences between these two genotypes35. There-
fore, a claim of zero apoptosis is hard to support with the 
current methods. A more sensitive approach may be the 
use of mice carrying the CAG-sA5-YFP transgene, which 
encodes a fluorescently labeled, secreted form of annexin V. 
The fluorescently labeled annexin V accumulates to detect-
able levels when binding to phosphatidylserine exposed on 
the surface of apoptotic cells37. A caveat here may be that 
necroptotic cells also stain positive for annexin V38.
Developmental processes less likely to require 
apoptosis
It was surprising that apoptosis, given its stereotypic occur-
rence, was not essential for C. elegans development8 and from 
time to time it was speculated that apoptosis in mammalian 
development, too, might be less critical than its prevalence 
might suggest39. Throughout the decades of intense research on 
the role of apoptosis in a number of developmental processes, 
information surfaced indicating that, despite previous inferences, 
apoptosis was not required for specific processes. An exam-
ple is the role of apoptosis in the formation of the pro-amniotic 
cavity, which was viewed as a model of cavity formation/tube 
formation by apoptosis and supported by work in in vivo 
and culture models15,40,41 but was later called into question by the 
development of embryos past this point in the absence of detect-
able apoptosis35. Similarly, apoptosis had been observed in the 
ridge of the closing neural folds and therefore it had been pro-
posed that neural tube closure required apoptotic cell death at 
the point where the two neural folds met. This was supported 
by the observation that the application of caspase inhibitors at a 
critical time point blocked neural tube closure18. On the 
surface, this conclusion appears to be amply supported by the 
many knockout mouse mutants of apoptotic regulators that dis-
play exencephaly or spina bifida or both (Bax;Bak;Bok TKO35, 
Trp53 KO32–34, Apaf1 KO42,43, Casp9 KO44,45, and Casp3;Casp7 
DKO46). However, one study presented evidence that apopto-
sis is not actually required for the specific time of neural tube 
closure and that lack of apoptosis did not affect tissue remod-
eling and separation of the neural tube from the surface 
ectoderm at the fusion site47. Similarly, it is not clear whether 
apoptosis is required at the specific time of palate fusion35,48–51.
The studies showing that neural tube closure and palate fusion 
can occur without developmental apoptosis raise the question 
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Table 2. Examples of developmental anomalies observed in mice after deletion of genes encoding regulators of apoptosis.
Gene deletion Major developmental phenotype (major adult phenotype) Reference
A1a Developmentally normal (accelerated neutrophil apoptosis) Hamasaki et al., 199852
Apaf1 Neural tube closure defect, delayed removal of interdigital webs Cecconi et al., 199842 
Yoshida et al., 199843
Bak Developmentally normal (platelet accumulation) Lindsten et al. 200053 
Mason et al. 200754
Bax Developmentally normal (lymphocyte accumulation, male infertility) Knudson et al., 199555
Bax;Bak DKO Defective removal of interdigital webs, vaginal septa, cell homeostasis in the 
forebrain neurogenic region and in the hematopoietic system
Lindsten et al., 200053
Bax;Bim DKO Webbed feet, male infertility (lymphocyte accumulation) Hutcheson et al., 200556
Bak;Bim DKO Developmentally normal (lymphocyte accumulation) Hutcheson et al., 200556
Bak;Bok DKO Developmentally normal Ke et al., 201357
Bax;Bok DKO Developmentally normal (in addition to Bax SKO phenotype, number of oocytes 
increased)
Ke et al., 201357
Bax;Bak;Bok TKO Midline fusion defects (exencephaly, spina bifida, omphalocele, cleft face/palate/
lip), webbed feet, vaginal septa, aortic arch defects, renal pelvis encroached by 
excess tissue, (supernumerary neurons and hematopoietic cells)
Ke et al., 201835 
Carpio et al., 201658
Bad Developmentally normal Ranger et al., 200359 
Kelly et al., 201060
Bclx Lethality at about E13.5, increased apoptosis of hematopoietic and neuronal cells 
(decreased platelet half-life)
Motoyama et al., 199561 
Mason et al. 200754
Bclx;Bim DKO Loss of BIM rescues hematopoietic and germ cells but not neuronal cell apoptosis 
in Bclx–/– mice
Akhtar et al., 200862
Bcl2 Developmentally normal (polycystic kidney, loss of lymphocytes) Veis et al., 199363
Bcl2;Bim DKO Developmentally normal (all defects caused by the loss of Bcl2 are rescued by the 
concomitant loss of Bim, including kidney, lymphocyte, and melanocytes) 
Bouillet et al., 200164
Bik Developmentally normal Coultas et al., 200465
Bim About 50% of Bim–/– mice are lost during embryogenesis prior to E10; others are 
developmentally normal and fertile (hematopoietic cell accumulation, autoimmune 
kidney disease).
Bouillet et al., 199966
Bim;Bmf DKO In addition to the Bim–/– phenotype, webbed feet, vaginal aplasia Labi et al., 201467
Bim;Bik DKO In addition to the Bim–/– phenotype, DKO display (male sterility) Coultas et al., 200568
Bim;Bad DKO In addition to the Bim–/– phenotype, slightly more lymphocyte accumulation Kelly et al., 201060
Bmf Vaginal atresia (lymphoid cell accumulation) Hubner et al., 201069 
Labi et al., 200870,201467
Bok Developmentally normal Ke et al., 201271
Casp3 Reduced neuronal apoptosis, neural hyperplasias, pre- and postnatal lethality Kuida et al., 199672
Casp3;Casp7 DKO Neural tube closure defect, heart anomalies Lakhani et al., 200646
Casp9 Neural tube closure defect Hakem et al., 199845 
Kuida et al., 199844
Hrk Developmentally normal Coultas et al., 200773
Mcl1 Embryonic lethality at the blastocyst stage prior to implantation Rinkenberger et al., 200074
Mcl1;Bclx 
compound hets
Craniofacial anomalies, including cases of holoprosencephaly, which are rescued 
by loss of one copy of Bim
Grabow et al., 201836
Mcl1;Bclx DKO Nervous system–specific DKO, neuronal apoptosis Fogarty et al., 201975
Puma Developmentally normal Villunger et al., 200376
Noxa Developmentally normal Villunger et al., 200376
Puma;Noxa DKO Developmentally normal Michalak et al., 200877
DKO, double knockout; E, embryonic day; hets, heterozygotes; SKO, single knockout; TKO, triple knockout.
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of why so many mouse mutants of critical constituents of the 
mitochondrial apoptotic pathway display exencephaly, spina 
bifida, and cleft palate (Table 2). A possible explanation is that it 
is not the process of tissue fusion that requires apoptosis but rather 
that apoptosis is important to arrive at body halves that are of a size 
compatible with the fusion process.
Death receptor pathway–induced apoptosis and 
necroptosis
Activation of the death receptor pathway can lead to apopto-
sis via caspase-8 activation or, when caspase-8 is inhibited, to 
necroptosis via RIPK1/RIPK3/MLKL activation (Figure 2). 
Death receptor pathway–mediated apoptosis is morphologically 
similar to mitochondrial apoptosis, but necroptosis is distinct, 
resembling necrosis. Disturbance of the normal regulation 
of death receptor–induced cell death pathways can result in 
developmental lethality. Mouse embryos lacking caspase-8 
display prenatal lethality78 and mice lacking RIPK1 die shortly 
after birth79 whereas RIPK3-deficient mice develop normally80. 
However, if both death receptor–activated processes (apoptosis 
and necroptosis) are inactivated by simultaneously deleting 
genes necessary for each process, the resulting mice are viable 
(for example, Casp8;Ripk3 DKO81,82; Casp8;Mlkl or Casp8;Fadd 
DKO83; and Ripk1;Ripk3;Casp8 or Ripk1;Ripk3;FADD TKO84). 
The studies using these compound mutant mice provided evi-
dence that death receptor–mediated apoptosis is not required 
for normal mouse development; rather, a balance between 
caspase-8 and RIPK1/RIPK3 activity needs to be maintained 
to prevent MLKL activation and consequent necroptosis. The 
observation that mice lacking MLKL85, the essential mediator 
of necroptosis, develop normally reveals that this programmed 
cell death process is not required for embryogenesis. In agree-
ment with these findings, early histological studies did not detect 
substantial involvement of necrotic processes in mammalian 
development.
Other forms of cell death and cell removal 
mechanisms
The most abundant form of developmental cell death appears 
to be apoptosis, and more specifically mitochondrial apop-
tosis, as the death receptor pathway does not appear to be 
essential for normal development (discussed above). Further-
more, reduction of mitochondrial apoptosis to below current 
detection levels by simultaneous deletion of Bax, Bak, and Bok 
did not appear to cause a compensatory increase in necrop-
tosis, pyroptosis, or autophagy35, suggesting that these other 
forms of cell death may not be poised to compensate for a 
deficiency of the mitochondrial apoptotic pathway.
A number of alternative cell removal processes have been pro-
posed to play a role during development, including entosis86, 
autophagy87,88, cell extrusion from epithelia1,89,90, and cell 
senescence91,92. However, their prominence and roles during 
mammalian development remain to be determined. Autophagy 
is morphologically distinct from apoptosis93 and so could 
be assessed and its frequency could be compared to apop-
tosis. An overlap between apoptosis and entosis exists in so 
far as apoptotic cells are eventually engulfed by other cells. 
Whether mammalian cells are extruded from epithelia (for 
example, in the intestine) before or after they have initiated cell 
death appears contentious1,94,95, and the ultimate fate of senes-
cent cells seems to be cell death, possibly mostly through 
apoptosis92.
Overall, the mitochondrial apoptotic pathway appears to 
be the major form of developmental cell death. However, it 
should be noted that low prevalence of a given process does not 
necessarily imply little importance. Accordingly, it is possi-
ble that in specific cases these alternative forms of cell death 
play an essential role during mammalian development, which 
remains to be functionally tested. This will probably require 
the generation and analysis of mice deficient in multiple 
cell death pathways and possibly even mice lacking several 
cell death pathways plus other processes (for example, cell 
senescence) to uncover redundancy.
Open questions
The following open questions exist in the field of 
developmental apoptosis.
 (1) The field might benefit from the results of a compre-
hensive, sensitive, and quantitative analysis of apoptosis 
throughout the sequence of mammalian development that 
either does not rely on tissue sections or uses sophisti-
cated methods of three-dimensional reconstruction and 
numerical assessment.
 (2) Once a sensitive technical approach to (1) has been 
developed, the question of whether developmental apop-
tosis is dynamically regulated during development in 
response to disruptions (for example, of proliferation or cell 
survival) could be answered.
 (3) If similarly sensitive and quantitative detection meth-
ods were developed for other forms of cell death, their 
relative importance compared with apoptosis could be 
assessed.
 (4) The role of a number of BCL-2 family members 
in development remains to be determined, while sin-
gle knockout of the genes encoding these does not result 
in overt phenotypic anomalies, which is possibly due to 
functional redundancies.
 (5) In addition, based on the theory of evolution, one 
would expect that even these BCL-2 family members have 
essential functions (that provide a selective advantage), 
which remain to be discovered.
Conclusions
The available data identify developmental processes that are 
clearly dependent on functional apoptosis, whereas other proc-
esses previously thought to depend on programmed cell death 
do not appear to be as reliant on apoptosis.
Processes apparently independent of apoptosis based on nor-
mal embryonic and fetal development in the combined absence 
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of BAX, BAK, and BOK include, for example, the forma-
tion of the pro-amniotic cavity, epiblast, intestine, and lens 
development as well as enchondral ossification. (For more details, 
see Table S2 in Ke et al., 201835.) However, the caveat that 
residual apoptosis not detectable by current methods (discussed 
in the preceding sections) needs to be kept in mind.
It is certainly curious that a complex and regulated process, 
such as apoptosis, occurs in an evolutionary conserved man-
ner during development, including in places where it appears 
to be largely or completely dispensable. One possibility is that 
apoptosis occurs as a by-product of other processes; for 
example, in the process of tissue remodeling, cells might 
lose their contact to the extracellular matrix and, without this 
survival signal, might die by apoptosis (anoikis).
Another possible explanation is that a twofold control of devel-
oping tissue size and cell population homeostasis by maintaining 
a balance between proliferation and cell death affords not just 
one but two cellular mechanisms of fine-tuning cell number. 
This would provide a more robust regulation, less prone to 
errors and variation in response to negative impact.
Indeed, mammalian and other embryos appear to have an 
astounding capacity to compensate for the loss of cells, cer-
tainly by upregulating cell proliferation96,97 but perhaps also by 
actively downregulating developmental apoptosis. It can be 
assumed, on the basis of its evolutionary conservation, that 
apoptotic cell death, even in regions where it is not absolutely 
required, provides a competitive advantage.
Acknowledgments
The authors thank Leigh Coultas of the Walter and Eliza Hall 
Institute of Medical Research, Australia, for critical reading 
of the manuscript.
References F1000 recommended
1.	 Glucksmann	A:	Cell deaths in normal vertebrate ontogeny.	Biol Rev Camb Philos 
Soc.	1951;	26(1):	59–86.		
PubMed Abstract |	Publisher Full Text 
2.	 	Kerr	JFR,	Wyllie	AH,	Currie	AR:	Apoptosis: A Basic Biological Phenomenon 
with Wide-ranging Implications in Tissue Kinetics.	Br J Cancer.	1972;	26(4):	
239–57.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
3.	 Fuchs	Y,	Steller	H:	Programmed cell death in animal development and disease.	
Cell.	2011;	147(4):	742–58.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
4.	 Czabotar	PE,	Lessene	G,	Strasser	A,	et al.:	Control of apoptosis by the BCL-2 
protein family: Implications for physiology and therapy.	Nat Rev Mol Cell Biol.	
2014;	15(1):	49–63.		
PubMed Abstract |	Publisher Full Text 
5.	 Green	DR,	Kroemer	G:	The pathophysiology of mitochondrial cell death.	
Science.	2004;	305(5684):	626–9.		
PubMed Abstract |	Publisher Full Text 
6.	 Strasser	A,	Harris	AW,	Huang	DC,	et al.:	Bcl-2 and Fas/APO-1 regulate distinct 
pathways to lymphocyte apoptosis.	EMBO J.	1995;	14(24):	6136–47.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
7.	 Shan	B,	Pan	H,	Najafov	A,	et al.:	Necroptosis in development and diseases.	
Genes Dev.	2018;	32(5-6):	327–40.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
8.	 	Ellis	H,	Horvitz	HR:	Genetic control of programmed cell death in the 
nematode C. elegans.	Cell.	1986;	44(6):	817–29.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
9.	 Ellis	RE,	Yuan	JY,	Horvitz	HR:	Mechanisms and functions of cell death.	Annu 
Rev Cell Biol.	1991;	7:	663–98.		
PubMed Abstract |	Publisher Full Text 
10.	 Strasser	A,	Vaux	DL:	Viewing BCL2 and cell death control from an evolutionary 
perspective.	Cell Death Differ.	2018;	25(1):	13–20.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
11.	 Pierce	GB,	Lewellyn	AL,	Parchment	RE:	Mechanism of programmed cell death in 
the blastocyst.	Proc Natl Acad Sci U S A.	1989;	86(10):	3654–8.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
12.	 Poelmann	RE:	Differential mitosis and degeneration patterns in relation to the 
alterations in the shape of the embryonic ectoderm of early post-implantation 
mouse embryos.	J Embryol Exp Morphol.	1980;	55:	33–51.		
PubMed Abstract 
13.	 Graham	A,	Heyman	I,	Lumsden	A:	Even-numbered rhombomeres control the 
apoptotic elimination of neural crest cells from odd-numbered rhombomeres 
in the chick hindbrain.	Development.	1993;	119(1):	233–45.		
PubMed Abstract 
14.	 Morgenbesser	SD,	Williams	BO,	Jacks	T,	et al.:	p53-dependent apoptosis 
produced by Rb-deficiency in the developing mouse lens.	Nature.	1994;	
371(6492):	72–4.		
PubMed Abstract |	Publisher Full Text 
15.	 Coucouvanis	E,	Martin	GR:	Signals for death and survival: A two-step 
mechanism for cavitation in the vertebrate embryo.	Cell.	1995;	83(2):	279–87.	
PubMed Abstract |	Publisher Full Text 
16.	 	Jacobsen	MD,	Weil	M,	Raff	MC:	Role of Ced-3/ICE-family proteases in 
staurosporine-induced programmed cell death.	J Cell Biol.	1996;	133(5):	1041–51.	
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
17.	 Macias	D,	Gañan	Y,	Sampath	TK:	et al.:	Role of BMP-2 and OP-1 (BMP-7) in 
programmed cell death and skeletogenesis during chick limb development.	
Development.	1997;	124(6):	1109–17.		
PubMed Abstract 
18.	 Weil	M,	Jacobson	MD,	Raff	MC:	Is programmed cell death required for neural 
tube closure?	Current Biology.	1997;	7(4):	281–4.		
PubMed Abstract |	Publisher Full Text 
19.	 Koseki	C,	Herzlinger	D,	al-Awqati	Q:	Apoptosis in metanephric development.		
J Cell Biol.	1992;	119(5):	1327–33.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
20.	 Coles	HS,	Burne	JF,	Raff	MC:	Large-scale normal cell death in the developing 
rat kidney and its reduction by epidermal growth factor.	Development.	1993;	
118(3):	777–84.		
PubMed Abstract 
21.	 Pan	H,	Griep	AE:	Temporally distinct patterns of p53-dependent and p53-
independent apoptosis during mouse lens development.	Genes Dev.	1995;	
9(17):	2157–69.		
PubMed Abstract |	Publisher Full Text 
22.	 Fekete	DM,	Homburger	SA,	Waring	MT,	et al.:	Involvement of programmed 
cell death in morphogenesis of the vertebrate inner ear.	Development.	1997;	
124(12):	2451–61.		
PubMed Abstract 
23.	 Amling	M,	Neff	L,	Tanaka	S,	et al.:	Bcl-2 Lies Downstream of Parathyroid 
Hormone-related Peptide in a Signaling Pathway That Regulates Chondrocyte 
Maturation during Skeletal Development.	J Cell Biol.	1997;	136(1):	205–13.	
PubMed Abstract |	Publisher Full Text |	Free Full Text 
24.	 Martínez-Alvarez	C,	Tudela	C,	Pérez-Miguelsanz	J,	et al.:	Medial edge epithelial 
cell fate during palatal fusion.	Dev Biol.	2000;	220(2):	343–57.		
PubMed Abstract |	Publisher Full Text 
25.	 	Monier	B,	Gettings	M,	Gay	G,	et al.:	Apico-basal forces exerted by apoptotic 
cells drive epithelium folding.	Nature.	2015;	518(7538):	245–8.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
26.	 White	LD,	Barone	S:	Qualitative and quantitative estimates of apoptosis from 
Page 9 of 12
F1000Research 2020, 9(F1000 Faculty Rev):148 Last updated: 26 FEB 2020
birth to senescence in the rat brain.	Cell Death Differ.	2001;	8(4):	345–56.	
PubMed Abstract |	Publisher Full Text 
27.	 Sun	W,	Gould	TW,	Vinsant	S,	et al.:	Neuromuscular Development after the 
Prevention of Naturally Occurring Neuronal Death by Bax Deletion.	J Neurosci.	
2003;	23(19):	7298–310.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
28.	 Fariñas	I,	Yoshida	CK,	Backus	C,	et al.:	Lack of Neurotrophin-3 Results in Death 
of Spinal Sensory Neurons and Premature Differentiation of Their Precursors.	
Neuron.	1996;	17(6):	1065–78.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
29.	 	Deppmann	CD,	Mihalas	S,	Sharma	N,	et al.:	A model for neuronal 
competition during development.	Science.	2008;	320(5874):	369–73.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
30.	 Vousden	KH,	Lane	DP:	p53 in health and disease.	Nat Rev Mol Cell Biol.	2007;	
8(4):	275–83.		
PubMed Abstract |	Publisher Full Text 
31.	 	Kastenhuber	ER,	Lowe	SW:	Putting p53 in Context.	Cell.	2017;	170(6):	1062–78.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
32.	 Armstrong	JF,	Kaufman	MH,	Harrison	DJ,	et al.:	High-frequency developmental 
abnormalities in p53-deficient mice.	Current Biology.	1995;	5(8):	931–6.		
PubMed Abstract |	Publisher Full Text 
33.	 Sah	VP,	Attardi	LD,	Mulligan	GJ,	et al.:	A subset of p53-deficient embryos exhibit 
exencephaly.	Nat Genet.	1995;	10(2):	175–80.		
PubMed Abstract |	Publisher Full Text 
34.	 Delbridge	ARD,	Kueh	AJ,	Ke	F,	et al.:	Loss of p53 Causes Stochastic Aberrant 
X-Chromosome Inactivation and Female-Specific Neural Tube Defects.	Cell 
Rep.	2019;	27(2):	442–454.e5.		
PubMed Abstract |	Publisher Full Text 
35.	 	Ke	FFS,	Vanyai	HK,	Cowan	AD,	et al.:	Embryogenesis and Adult Life in 
the Absence of Intrinsic Apoptosis Effectors BAX BAK, and BOK.	Cell.	2018;	
173(5):	1217–1230.e17.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
36.	 	Grabow	S,	Kueh	AJ,	Ke	F,	et al.:	Subtle Changes in the Levels of BCL-2 
Proteins Cause Severe Craniofacial Abnormalities.	Cell Rep.	2018;	24(12):	
3285–3295.e4.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
37.	 	Martínez-Lagunas	K,	Yamaguchi	Y,	Becker	C,	et al.:	In vivo detection of 
programmed cell death during mouse heart development.	Cell Death Differ.	
2019;	88:	347.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
38.	 	Gong	YN,	Guy	C,	Olauson	H,	et al.:	ESCRT-III Acts Downstream of MLKL 
to Regulate Necroptotic Cell Death and Its Consequences.	Cell.	2017;	169(2):	
286–300.e16.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
39.	 	Tuzlak	S,	Kaufmann	T,	Villunger	A:	Interrogating the relevance of 
mitochondrial apoptosis for vertebrate development and postnatal tissue 
homeostasis.	Genes Dev.	2016;	30(19):	2133–51.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
40.	 Brown	D,	Yu	BD,	Joza	N,	et al.:	Loss of Aif function causes cell death in the 
mouse embryo, but the temporal progression of patterning is normal.	Proc Natl 
Acad Sci U S A.	2006;	103(26):	9918–23.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
41.	 Joza	N,	Susin	SA,	Daugas	E,	et al.:	Essential role of the mitochondrial 
apoptosis-inducing factor in programmed cell death.	Nature.	2001;	410(6828):	
549–54.		
PubMed Abstract |	Publisher Full Text 
42.	 Cecconi	F,	Alvarez-Bolado	G,	Meyer	BI,	et al.:	Apaf1 (CED-4 homolog) regulates 
programmed cell death in mammalian development.	Cell.	1998;	94(6):	727–37.	
PubMed Abstract |	Publisher Full Text 
43.	 Yoshida	H,	Kong	YY,	Yoshida	R,	et al.:	Apaf1 is required for mitochondrial 
pathways of apoptosis and brain development.	Cell.	1998;	94(6):	739–50.	
PubMed Abstract |	Publisher Full Text 
44.	 Kuida	K,	Haydar	TF,	Kuan	CY,	et al.:	Reduced apoptosis and cytochrome 
c-mediated caspase activation in mice lacking caspase 9.	Cell.	1998;	94(3):	
325–37.		
PubMed Abstract |	Publisher Full Text 
45.	 Hakem	R,	Hakem	A,	Duncan	GS,	et al.:	Differential requirement for caspase 9 in 
apoptotic pathways in vivo.	Cell.	1998;	94(3):	339–52.		
PubMed Abstract |	Publisher Full Text 
46.	 	Lakhani	SA,	Masud	A,	Kuida	K,	et al.:	Caspases 3 and 7: key mediators of 
mitochondrial events of apoptosis.	Science.	2006;	311(5762):	847–51.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
47.	 	Massa	V,	Savery	D,	Ybot-Gonzalez	P,	et al.:	Apoptosis is not required for 
mammalian neural tube closure.	Proc Natl Acad Sci U S A.	2009;	106(20):	8233–8.	
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
48.	 Cuervo	R,	Valencia	C,	Chandraratna	RA,	et al.:	Programmed cell death is 
required for palate shelf fusion and is regulated by retinoic acid.	Dev Biol.	
2002;	245(1):	145–56.		
PubMed Abstract |	Publisher Full Text 
49.	 Fitchett	JE,	Hay	ED:	Medial edge epithelium transforms to mesenchyme after 
embryonic palatal shelves fuse.	Dev Biol.	1989;	131(2):	455–74.		
PubMed Abstract |	Publisher Full Text 
50.	 Shuler	CF,	Halpern	DE,	Guo	Y,	et al.:	Medial edge epithelium fate traced by cell 
lineage analysis during epithelial-mesenchymal transformation in vivo.	Dev 
Biol.	1992;	154(2):	318–30.		
PubMed Abstract |	Publisher Full Text 
51.	 Takahara	S,	Takigawa	T,	Shiota	K:	Programmed cell death is not a necessary 
prerequisite for fusion of the fetal mouse palate.	Int J Dev Biol.	2004;	48(1):	
39–46.		
PubMed Abstract |	Publisher Full Text 
52.	 Hamasaki	A,	Sendo	F,	Nakayama	K,	et al.:	Accelerated neutrophil apoptosis in 
mice lacking A1-a, a subtype of the bcl-2-related A1 gene.	J Exp Med.	1998;	
188(11):	1985–92.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
53.	 Lindsten	T,	Ross	AJ,	King	A,	et al.:	The Combined Functions of Proapoptotic 
Bcl-2 Family Members Bak and Bax Are Essential for Normal Development of 
Multiple Tissues.	Mol Cell.	2000;	6(6):	1389–99.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
54.	 	Mason	KD,	Carpinelli	MR,	Fletcher	JI,	et al.:	Programmed anuclear cell death 
delimits platelet life span.	Cell.	2007;	128(6):	1173–86.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
55.	 	Knudson	CM,	Tung	KS,	Tourtellotte	WG,	et al.:	Bax-Deficient Mice with 
Lymphoid Hyperplasia and Male Germ Cell Death.	Science.	1995;	270(5233):	
96–9.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
56.	 Hutcheson	J,	Scatizzi	JC,	Bickel	E,	et al.:	Combined loss of proapoptotic genes 
Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in 
thymocyte apoptosis.	J Exp Med.	2005;	201(12):	1949–60.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
57.	 Ke	F,	Bouillet	P,	Kaufmann	T,	et al.:	Consequences of the combined loss of BOK 
and BAK or BOK and BAX.	Cell Death Dis.	2013;	4:	e650.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
58.	 Carpio	MA,	Michaud	M,	Zhou	W,	et al.:	Reply to Fernandez-Marrero et al.: Role 
of BOK at the intersection of endoplasmic reticulum stress and apoptosis 
regulation.	Proc Natl Acad Sci U S A.	2016;	113(5):	E494–E495.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
59.	 Ranger	AM,	Zha	J,	Harada	H,	et al.:	Bad-deficient mice develop diffuse large B 
cell lymphoma.	Proc Natl Acad Sci U S A.	2011;	100(16):	9324–9.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
60.	 Kelly	PN,	White	MJ,	Goschnick	MW,	et al.:	Individual and overlapping roles of 
BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets 
and in suppression of thymic lymphoma development.	Cell Death Differ.	2010;	
17(10):	1655–64.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
61.	 	Motoyama	N,	Wang	F,	Roth	K,	et al.:	Massive cell death of immature 
hematopoietic cells and neurons in Bcl-x-deficient mice.	Science.	1995;	
267(5203):	1506–10.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
62.	 Akhtar	RS,	Klocke	BJ,	Strasser	A,	et al.:	Loss of BH3-only protein Bim inhibits 
apoptosis of hemopoietic cells in the fetal liver and male germ cells but not 
neuronal cells in bcl-x-deficient mice.	J Histochem Cytochem.	2008;	56(10):	
921–7.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
63.	 Veis	DJ,	Sorenson	CM,	Shutter	JR,	et al.:	Bcl-2-deficient mice demonstrate 
fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.	
Cell.	1993;	75(2):	229–40.		
PubMed Abstract |	Publisher Full Text 
64.	 	Bouillet	P,	Cory	S,	Zhang	LC,	et al.:	Degenerative disorders caused by Bcl-2 
deficiency prevented by loss of its BH3-only antagonist Bim.	Dev Cell.	2001;	
1(5):	645–53.		
PubMed Abstract |	Publishe.r Full Text | F1000 Recommendation 
65.	 Coultas	L,	Bouillet	P,	Stanley	EG,	et al.:	Proapoptotic BH3-only Bcl-2 family 
member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but 
is redundant for their programmed death.	Mol Cell Biol.	2004;	24(4):	1570–81.	
PubMed Abstract |	Publisher Full Text |	Free Full Text 
66.	 Bouillet	P,	Metcalf	D,	Huang	DC,	et al.:	Proapoptotic Bcl-2 relative Bim required 
for certain apoptotic responses, leukocyte homeostasis, and to preclude 
autoimmunity.	Science.	1999;	286(5445):	1735–8.		
PubMed Abstract |	Publisher Full Text 
67.	 Labi	V,	Woess	C,	Tuzlak	S,	et al.:	Deregulated cell death and lymphocyte 
homeostasis cause premature lethality in mice lacking the BH3-only proteins 
Bim and Bmf.	Blood.	2014;	123(17):	2652–62.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
68.	 Coultas	L,	Bouillet	P,	Loveland	KL,	et al.:	Concomitant loss of proapoptotic BH3-
only Bcl-2 antagonists Bik and Bim arrests spermatogenesis.	EMBO J.	2005;	
24(22):	3963–73.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
69.	 Hübner	A,	Cavanagh-Kyros	J,	Rincon	M,	et al.:	Functional cooperation of the 
proapoptotic Bcl2 family proteins Bmf and Bim in vivo.	Mol Cell Biol.	2009;	
30(1):	98–105.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
70.	 	Labi	V,	Erlacher	M,	Kiessling	S,	et al.:	Loss of the BH3-only protein Bmf 
Page 10 of 12
F1000Research 2020, 9(F1000 Faculty Rev):148 Last updated: 26 FEB 2020
impairs B cell homeostasis and accelerates gamma irradiation-induced thymic 
lymphoma development.	J Exp Med.	2008;	205(3):	641–55.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
71.	 Ke	F,	Voss	A,	Kerr	JB,	et al.:	BCL-2 family member BOK is widely expressed but 
its loss has only minimal impact in mice.	Cell Death Differ.	2012;	19(6):	915–25.	
PubMed Abstract |	Publisher Full Text |	Free Full Text 
72.	 	Kuida	K,	Zheng	TS,	Na	S,	et al.:	Decreased apoptosis in the brain and 
premature lethality in CPP32-deficient mice.	Nature.	1996;	384(6607):	368–72.	
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
73.	 Coultas	L,	Terzano	S,	Thomas	T,	et al.:	Hrk/DP5 contributes to the apoptosis 
of select neuronal populations but is dispensable for haematopoietic cell 
apoptosis.	J Cell Sci.	2007;	120(Pt	12):	2044–52.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
74.	 Rinkenberger	JL,	Horning	S,	Klocke	B,	et al.:	Mcl-1 deficiency results in peri-
implantation embryonic lethality.	Genes Dev.	2000;	14(1):	23–7.		
PubMed Abstract |	Free Full Text 
75.	 Fogarty	LC,	Flemmer	RT,	Geizer	BA,	et al.:	Mcl-1 and Bcl-xL are essential for 
survival of the developing nervous system.	Cell Death Differ.	2019;	26(8):		
1501–15.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
76.	 	Villunger	A,	Michalak	EM,	Coultas	L,	et al.:	p53- and drug-induced apoptotic 
responses mediated by BH3-only proteins puma and noxa.	Science.	2003;	
302(5647):	1036–8.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
77.	 Michalak	EM,	Villunger	A,	Adams	JM,	et al.:	In several cell types tumour 
suppressor p53 induces apoptosis largely via Puma but Noxa can contribute.	
Cell Death Differ.	2008;	15(6):	1019–29.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
78.	 Varfolomeev	EE,	Schuchmann	M,	Luria	V,	et al.:	Targeted disruption of the 
mouse Caspase 8 gene ablates cell death induction by the TNF receptors, 
Fas/Apo1, and DR3 and is lethal prenatally.	Immunity.	1998;	9(2):	267–76.		
PubMed Abstract |	Publisher Full Text 
79.	 Kelliher	MA,	Grimm	S,	Ishida	Y,	et al.:	The death domain kinase RIP mediates 
the TNF-induced NF-kappaB signal.	Immunity.	1998;	8(3):	297–303.		
PubMed Abstract |	Publisher Full Text 
80.	 Newton	K,	Sun	X,	Dixit	VM:	Kinase RIP3 is dispensable for normal NF-kappa Bs, 
signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, 
and Toll-like receptors 2 and 4.	Mol Cell Biol.	2004;	24(4):	1464–9.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
81.	 	Kaiser	WJ,	Upton	JW,	Long	AB,	et al.:	RIP3 mediates the embryonic lethality 
of caspase-8-deficient mice.	Nature.	2011;	471(7338):	368–72.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
82.	 	Oberst	A,	Dillon	CP,	Weinlich	R,	et al.:	Catalytic activity of the caspase-8-
FLIP(L) complex inhibits RIPK3-dependent necrosis.	Nature.	2011;	471(7338):	
363–7.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
83.	 Alvarez-Diaz	S,	Dillon	CP,	Lalaoui	N,	et al.:	The Pseudokinase MLKL and the 
Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of 
Death-Receptor-Induced Apoptosis.	Immunity.	2016;	45(3):	513–26.		
PubMed Abstract |	Publisher Full Text |	Free Full Text 
84.	 	Dillon	CP,	Weinlich	R,	Rodriguez	DA,	et al.:	RIPK1 blocks early postnatal 
lethality mediated by caspase-8 and RIPK3.	Cell.	2014;	157(5):	1189–202.	
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
85.	 Murphy	JM,	Czabotar	PE,	Hildebrand	JM,	et al.:	The pseudokinase MLKL 
mediates necroptosis via a molecular switch mechanism.	Immunity.	2013;	39(3):	
443–53.		
PubMed Abstract |	Publisher Full Text 
86.	 	Overholtzer	M,	Mailleux	AA,	Mouneimne	G,	et al.:	A nonapoptotic cell death 
process, entosis, that occurs by cell-in-cell invasion.	Cell.	2007;	131(5):	966–79.	
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
87.	 	Fimia	GM,	Stoykova	A,	Romagnoli	A,	et al.:	Ambra1 regulates autophagy and 
development of the nervous system.	Nature.	2007;	447(7148):	1121–5.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
88.	 	Qu	X,	Zou	Z,	Sun	Q,	et al.:	Autophagy gene-dependent clearance of 
apoptotic cells during embryonic development.	Cell.	2007;	128(5):	931–46.	
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
89.	 	Denning	DP,	Hatch	V,	Horvitz	HR:	Programmed elimination of cells by 
caspase-independent cell extrusion in C. elegans.	Nature.	2012;	488(7410):	
226–30.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
90.	 	Eisenhoffer	GT,	Loftus	PD,	Yoshigi	M,	et al.:	Crowding induces live cell 
extrusion to maintain homeostatic cell numbers in epithelia.	Nature.	2012;	
484(7395):	546–9.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
91.	 	Muñoz-Espín	D,	Cañamero	M,	Maraver	A,	et al.:	Programmed cell 
senescence during mammalian embryonic development.	Cell.	2013;	155(5):	
1104–18.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
92.	 	Storer	M,	Mas	A,	Robert-Moreno	A,	et al.:	Senescence is a developmental 
mechanism that contributes to embryonic growth and patterning.	Cell.	2013;	
155(5):	1119–30.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
93.	 	Kroemer	G,	Galluzzi	L,	Vandenabeele	P,	et al.:	Classification of cell death: 
recommendations of the Nomenclature Committee on Cell Death 2009.	Cell 
Death Differ.	2009;	16(1):	3–11.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
94.	 Abud	HE,	Heath	JK:	Detecting apoptosis during the formation of polarized 
intestinal epithelium in organ culture.	Cell Death Differ.	2004;	11(7):	788–9.	
PubMed Abstract |	Publisher Full Text 
95.	 	Michael	M,	Meiring	JCM,	Acharya	BR,	et al.:	Coronin 1B Reorganizes 
the Architecture of F-Actin Networks for Contractility at Steady-State and 
Apoptotic Adherens Junctions.	Dev Cell.	2016;	37(1):	58–71.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
96.	 	Fogarty	CE,	Bergmann	A:	Killers creating new life: caspases drive 
apoptosis-induced proliferation in tissue repair and disease.	Cell Death Differ.	
2017;	24(8):	1390–400.		
PubMed Abstract |	Publisher Full Text |	Free Full Text | F1000 Recommendation 
97.	 	Freret-Hodara	B,	Cui	Y,	Griveau	A,	et al.:	Enhanced Abventricular 
Proliferation Compensates Cell Death in the Embryonic Cerebral Cortex.	Cereb 
Cortex.	2017;	27(10):	4701–18.		
PubMed Abstract |	Publisher Full Text | F1000 Recommendation 
Page 11 of 12
F1000Research 2020, 9(F1000 Faculty Rev):148 Last updated: 26 FEB 2020
 Open Peer Review
   Current Peer Review Status:
Editorial Note on the Review Process
 are written by members of the prestigious  . They are commissioned andF1000 Faculty Reviews F1000 Faculty
are peer reviewed before publication to ensure that the final, published version is comprehensive and accessible.
The reviewers who approved the final version are listed with their names and affiliations.
The reviewers who approved this article are:
Version 1
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias
You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative
Your article is indexed in PubMed after passing peer review
Dedicated customer support at every stage
For pre-submission enquiries, contact   research@f1000.com
 Jacqueline L. Vanderluit
Division of BioMedical Sciences, Memorial University, St. John's, NF, Canada
 No competing interests were disclosed.Competing Interests:
1
 Andrew Copp
Developmental Biology and Cancer, University College London Great Ormond Street Institute of Child Health,
London, UK
 No competing interests were disclosed.Competing Interests:
2
 Andreas Villunger
Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria
 No competing interests were disclosed.Competing Interests:
3
Page 12 of 12
F1000Research 2020, 9(F1000 Faculty Rev):148 Last updated: 26 FEB 2020
